Candriam SCA’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $116M | Buy |
982,258
+7,387
| +0.8% | +$853K | 0.52% | 38 |
|
|
2026
Q1 | $116M | Buy |
974,871
+213,448
| +28% | +$28M | 0.61% | 30 |
|
|
2025
Q4 | $104M | Buy |
761,423
+205,821
| +37% | +$29.6M | 0.52% | 34 |
|
|
2025
Q3 | $82M | Buy |
555,602
+57,559
| +12% | +$7.98M | 0.43% | 48 |
|
|
2025
Q2 | $64.4M | Buy |
498,043
+57,332
| +13% | +$6.94M | 0.37% | 65 |
|
|
2025
Q1 | $52.6M | Sell |
440,711
-227,973
| -34% | -$28.3M | 0.33% | 78 |
|
|
2024
Q4 | $77.6M | Buy |
668,684
+127,651
| +24% | +$16.1M | 0.45% | 48 |
|
|
2024
Q3 | $73.1M | Buy |
541,033
+236,871
| +78% | +$31.7M | 0.42% | 51 |
|
|
2024
Q2 | $41.3M | Buy |
304,162
+28,999
| +11% | +$3.95M | 0.25% | 88 |
|
|
2024
Q1 | $35.6M | Buy |
275,163
+11,414
| +4% | +$1.38M | 0.23% | 103 |
|
|
2023
Q4 | $30.2M | Buy |
263,749
+62,736
| +31% | +$6.26M | 0.21% | 113 |
|
|
2023
Q3 | $18.2M | Buy |
201,013
+61,132
| +44% | +$6.31M | 0.13% | 153 |
|
|
2023
Q2 | $15.8M | Sell |
139,881
-77,552
| -36% | -$8.2M | 0.11% | 188 |
|
|
2023
Q1 | $21M | Sell |
217,433
-27,975
| -11% | -$2.92M | 0.15% | 160 |
|
|
2022
Q4 | $27.1M | Sell |
245,408
-41,219
| -14% | -$4.32M | 0.18% | 131 |
|
|
2022
Q3 | $25M | Sell |
286,627
-9,064
| -3% | -$824K | 0.18% | 128 |
|
|
2022
Q2 | $23.1M | Buy |
295,691
+8,989
| +3% | +$742K | 0.19% | 127 |
|
|
2022
Q1 | $24.4M | Sell |
286,702
-63,204
| -18% | -$6.06M | 0.17% | 137 |
|
|
2021
Q4 | $42M | Buy |
349,906
+39,295
| +13% | +$4.88M | 0.27% | 96 |
|
|
2021
Q3 | $38.4M | Buy |
310,611
+12,180
| +4% | +$1.57M | 0.26% | 93 |
|
|
2021
Q2 | $35.8M | Sell |
298,431
-50,684
| -15% | -$5.79M | 0.25% | 96 |
|
|
2021
Q1 | $34.1M | Hold |
349,115
| – | – | 0.28% | 85 |
|
|
2020
Q4 | $35.5M | Buy |
349,115
+59,120
| +20% | +$5.56M | 0.28% | 85 |
|
|
2020
Q3 | $24.4M | Buy |
289,995
+11,168
| +4% | +$869K | 0.23% | 108 |
|
|
2020
Q2 | $18.1M | Sell |
278,827
-246,681
| -47% | -$16.3M | 0.19% | 131 |
|
|
2020
Q1 | $40.5M | Buy |
525,508
+31
| +0% | +$2.44K | 0.45% | 47 |
|
|
2019
Q4 | $41.5M | Buy |
525,477
+51,364
| +11% | +$4M | 0.44% | 47 |
|
|
2019
Q3 | $37.7M | Buy |
474,113
+46,293
| +11% | +$3.64M | 0.5% | 38 |
|
|
2019
Q2 | $35.6M | Buy |
427,820
+170,552
| +66% | +$13.6M | 0.44% | 43 |
|
|
2019
Q1 | $20.3M | Buy |
257,268
+32,884
| +15% | +$2.4M | 0.26% | 87 |
|
|
2018
Q4 | $15M | Buy |
224,384
+48,869
| +28% | +$3.38M | 0.23% | 101 |
|
|
2018
Q3 | $14M | Sell |
175,515
-17,540
| -9% | -$1.31M | 0.19% | 130 |
|
|
2018
Q2 | $13M | Buy |
193,055
+42,796
| +28% | +$3.11M | 0.21% | 124 |
|
|
2018
Q1 | $11.6M | Sell |
150,259
-11,633
| -7% | -$860K | 0.2% | 134 |
|
|
2017
Q4 | $11M | Buy |
161,892
+3,493
| +2% | +$232K | 0.19% | 143 |
|
|
2017
Q3 | $9.92M | Sell |
158,399
-23,939
| -13% | -$1.43M | 0.17% | 159 |
|
|
2017
Q2 | $10.1M | Buy |
182,338
+94,266
| +107% | +$4.91M | 0.19% | 146 |
|
|
2017
Q1 | $4.42M | Buy |
88,072
+66,271
| +304% | +$3.23M | 0.09% | 275 |
|
|
2016
Q4 | $1.08M | Sell |
21,801
-98,612
| -82% | -$5M | 0.02% | 504 |
|
|
2016
Q3 | $6.32M | Sell |
120,413
-2,118
| -2% | -$104K | 0.15% | 159 |
|
|
2016
Q2 | $5.47M | Sell |
122,531
-23,966
| -16% | -$1.04M | 0.14% | 167 |
|
|
2016
Q1 | $5.96M | Buy |
146,497
+48,081
| +49% | +$1.77M | 0.15% | 159 |
|
|
2015
Q4 | $3.59M | Sell |
98,416
-106,571
| -52% | -$3.85M | 0.1% | 225 |
|
|
2015
Q3 | $6.73M | Sell |
204,987
-200,928
| -50% | -$6.76M | 0.17% | 158 |
|
|
2015
Q2 | $15M | Buy |
405,915
+396,954
| +4,430% | +$14.4M | 0.31% | 84 |
|
|
2015
Q1 | $314K | Sell |
8,961
-3,614
| -29% | -$127K | 0.01% | 587 |
|
|
2014
Q4 | $479K | Buy |
+12,575
| New | +$460K | 0.01% | 527 |
|
Other funds holding XYL
Candriam SCA's XYL Position: Q2 2026 in Review
Candriam SCA increased its Xylem (XYL) stake by 0.76% in Q2 2026, buying an estimated $853K and bringing the position to 982,258 shares worth $116M. The position accounts for 0.52% of the portfolio, ranked #38.
Candriam SCA first reported a position in XYL in Q4 2014 and has held it in 47 quarters since. The position peaked at $116M in Q1 2026. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Candriam SCA held 982,258 shares of Xylem worth $116M as of Q2 2026.
- Candriam SCA bought 7,387 Xylem shares in Q2 2026, an estimated $853K.
- Xylem made up 0.52% of Candriam SCA's portfolio in Q2 2026, its #38 holding.
- Candriam SCA first reported a position in Xylem in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Xylem position peaked at $116M in Q1 2026.
- 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.